Literature DB >> 10228981

Effects of a phosphate buffered extracellular (Ep4) solution in preservation and reperfusion injury in the canine liver.

Y Kawashima1, S Ohwada, K Sakata, T Ohya, N Tomizawa, I Takeyoshi, Y Morishita.   

Abstract

The Ep4 solution, a phosphate buffered extracellular-type solution, is effective in canine lung transplantation following a 96-hour hypothermic (4 degrees C) preservation. In this experiment, we used this solution for liver preservation followed by transplantation. We compared the Ep4 solution with the lactated Ringer's (LR) and the Collins' M (CM) solution (a phosphate buffered intracellular-type solution) in two studies, 1) 48-hour liver preservation, and 2) orthotopic liver transplantation after 5-hour preservation. In the preservation study, purine nucleoside phosphorylase (PNP) levels as a marker of endothelial damage, and alanine aminotransferase (ALT) levels were significantly lower in the livers immersed into the Ep4 solution than in those immersed into other solutions at 36 and 48 hours after preservation. Microscopically, the endothelial injury occurred 24 hours after preservation in the CM solution, and 36 hours after preservation in the LR and Ep4 solutions. In the transplantation study, serum PNP and ALT levels in the livers immersed in Ep4 solution showed a lower tendency compared with those in other solutions at the time of reperfusion, but the histological differences among three groups were not apparent. The present study suggests that the liver can be stored better for a longer time using Ep4 solution than using LR and CM solutions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10228981     DOI: 10.1620/tjem.187.99

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  1 in total

1.  Impact of prolonged cold preservation on the graft function and gene expression levels in an experimental lung transplantation model.

Authors:  Osamu Yoshida; Masaomi Yamane; Sumiharu Yamamoto; Mikio Okazaki; Shinichi Toyooka; Takahiro Oto; Yoshifumi Sano; Shinichiro Miyoshi
Journal:  Surg Today       Date:  2012-06-27       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.